“Sonidegib Duration of Response in Advanced Basal Cell Carcinoma: Long-Term Results from the Phase 2 BOLT Trial”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S50, https://doi.org/10.25251/skin.2.supp.50.